Results 101 to 110 of about 332,762 (159)

Urinary Retention Triggered by Urethritis in Olanzapine-induced Diabetic Ketoacidosis. [PDF]

Intern Med
Murakami H, Norita K, Ikeda A.
europepmc   +1 more source

Risk predictive value of white blood cell count in patients with diabetes‑associated lower urinary tract symptoms: A population-based study. [PDF]

Clinics (Sao Paulo)
Liu N, Zhou D, Cao N.
europepmc   +1 more source

Inflammatory and neuroimmune imbalance in diabetic incontinence: insights from serum biomarker profiling. [PDF]

BMC Urol
Albaz AC, Kosova F, Temeltaş G, Üçer O, Müezzi̇noğlu T.   +4 more
europepmc   +1 more source

Management of Urinary Retention in Older Women. [PDF]

Drugs Aging
Sridhar R, Marantidis J, Cameron AP, Cameron AP.   +3 more
europepmc   +1 more source

The effect of aerobic exercise on bladder function and lower urinary tract symptoms in women who have diabetes mellitus with lower urinary tract symptoms: a randomized controlled. [PDF]

Ir J Med Sci
Tufekci B, Usgu G, Tufekci A.
europepmc   +1 more source

Stem Cell-Based Strategies for Fibrotic and Neurogenic Bladder Disorders: Current Evidence, Translational Challenges, and Future Directions. [PDF]

Curr Issues Mol Biol
Kim JH, Song M, Song YS.
europepmc   +1 more source

Sacral Neuromodulation Outcomes for Managing Urinary Incontinence in Patients With Overactive and Neurogenic Bladder. [PDF]

Cureus
Nugent C, Carreño Galeano G, Choi K.
europepmc   +1 more source

Risperidone-Induced Urinary Retention: A Case Report Highlighting Urological Complications in Long-Term Use of Antipsychotic Medication. [PDF]

Cureus
Bin Zaal K, Agha A, Elmekresh A, Abuhejleh SM, Mahjoor Azad E, Saeedi Y, Bagheri F.   +6 more
europepmc   +1 more source

Extracellular vesicles derived from human amniotic fluid stem cells improve bladder dysfunction in rat model of diabetic atherosclerosis. [PDF]

World J Stem Cells
Liang CC, Lin YH, Liang CY, Ro A, Huang YH, Shaw SW.   +5 more
europepmc   +1 more source

Nerve Growth Factor in Diabetes Mellitus: Pathophysiological Mechanisms, Biomarkers and Therapeutic Opportunities. [PDF]

Pharmaceuticals (Basel)
Massimino M, Rubino M, Natale MR, Salerno L, Belviso S, Mancuso E, Dagostino A, Demasi D, Barreca F, Averta C, Palummo A, Mannino GC, Andreozzi F.   +12 more
europepmc   +1 more source